RPM

111.62

-0.84%↓

NGR

9.52

-8.29%↓

FUL

58.82

+0.56%↑

TMQ

6.47

-8.74%↓

MSB

30.66

+1.25%↑

RPM

111.62

-0.84%↓

NGR

9.52

-8.29%↓

FUL

58.82

+0.56%↑

TMQ

6.47

-8.74%↓

MSB

30.66

+1.25%↑

RPM

111.62

-0.84%↓

NGR

9.52

-8.29%↓

FUL

58.82

+0.56%↑

TMQ

6.47

-8.74%↓

MSB

30.66

+1.25%↑

RPM

111.62

-0.84%↓

NGR

9.52

-8.29%↓

FUL

58.82

+0.56%↑

TMQ

6.47

-8.74%↓

MSB

30.66

+1.25%↑

RPM

111.62

-0.84%↓

NGR

9.52

-8.29%↓

FUL

58.82

+0.56%↑

TMQ

6.47

-8.74%↓

MSB

30.66

+1.25%↑

Kodu・Aktsiate loetelu・AdvanSix Inc

AdvanSix Inc

Suletud

SektorToorained

19.65 1.13

Osta Müü

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

19.15

Max

19.97

Põhinäitajad
By Trading Economics
Sissetulek	8M 31M
Müük	32M 410M
P/E Sektori keskmine	7.25 88.876
Dividenditootlus	3.11
Kasumimarginaal	7.651
Töötajad	1,450
EBITDA	-38M -30M

Soovitused
By TipRanks
Soovitused	Osta
12 kuu keskmine prognoos	+43.74% upside

Dividendid
By Dow Jones
Dividenditootlus Sektori keskmine	3.11% 3.28%
Järgmine tulemuste avaldamine	7. nov 2025
Järgmine dividendimakse kuupäev	25. nov 2025
Järgmine aktsia dividendi kuupäev (ex-date)	11. nov 2025

Turustatistika
By TradingEconomics
Turukapital	-20M 553M
Eelmine avamishind	18.52
Eelmine sulgemishind	19.65

Tehniline skoor

By Trading Central

Kindlus

Bullish Evidence

21.435 / 23.29 Toetus ja vastupanu

AdvanSix Inc Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

17. okt 2025, 18:13 UTC

Suurimad hinnamuutused turgudel

Revolution Medicines Rises as FDA Grants Priority Designation for Cancer Treatment

17. okt 2025, 17:05 UTC

Suurimad hinnamuutused turgudel

Artiva Biotherapeutics Shares Jump After Treatment Gets Fast Tracked

17. okt 2025, 15:03 UTC

Suurimad hinnamuutused turgudel

Obook Shares Sink Following Public Debut

17. okt 2025, 14:41 UTC

Suurimad hinnamuutused turgudel

Disc Medicine Shares Surge After FDA Grants Priority Voucher for EPP Drug

17. okt 2025, 23:25 UTC

Omandamised, ülevõtmised, äriostud

New Zealand's 'Golden Visa' Targets the Affluent in Search of Plan B -- Barrons.com

17. okt 2025, 22:15 UTC

Market Talk

Ulta's CFO Appointment Seen Supporting Growth -- Market Talk

17. okt 2025, 21:15 UTC

Market Talk

Greece Expected to Post Overall Budgetary Surplus This Year -- Market Talk

17. okt 2025, 21:07 UTC

Market Talk

Oracle Stock Expected to Take a Breather as Capex Climbs -- Market Talk

17. okt 2025, 21:07 UTC

Market Talk

Global Equities Roundup: Market Talk

17. okt 2025, 20:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

17. okt 2025, 20:34 UTC

Market Talk

Deere Is Reaching the End of Its Downcycle -- Market Talk

17. okt 2025, 20:27 UTC

Market Talk

Soft Growth Ahead in Canada But Not Far Off From Potential GDP, Macklem Says -- Market Talk

17. okt 2025, 19:46 UTC

Market Talk

U.S. Natural Gas Futures Snap Losing Streak -- Market Talk

17. okt 2025, 19:45 UTC

Market Talk

Oil Futures Stabilize, But End Week With A Loss -- Market Talk

17. okt 2025, 18:45 UTC

Market Talk

Treasury Yields, Dollar Try to Reclaim Some Ground -- Market Talk

17. okt 2025, 17:51 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

17. okt 2025, 17:51 UTC

Market Talk

Euro Still a Long Way From Supplanting Dollar, Former ECB Rate Setter Says -- Market Talk

17. okt 2025, 17:44 UTC

Market Talk

EQT Seen With Long-Term Growth Opportunities -- Market Talk

17. okt 2025, 17:35 UTC

Market Talk

U.S. Oil Rig Count Unchanged at 418 -- Market Talk

17. okt 2025, 16:20 UTC

Market Talk

Tulu

Tech, Media & Telecom Roundup: Market Talk

17. okt 2025, 16:20 UTC

Market Talk

Basic Materials Roundup: Market Talk

17. okt 2025, 16:14 UTC

Market Talk

Home Depot Will Gain From Pick Up in Home Improvement Activity -- Market Talk

17. okt 2025, 16:04 UTC

Market Talk

Home Improvement Demand Is Starting to Pick Up -- Market Talk

17. okt 2025, 15:58 UTC

Market Talk

Amazon's Project Rainier Will Begin to Stem Its AI Share Losses -- Market Talk

17. okt 2025, 15:56 UTC

Tulu

These Stocks Are Moving the Most Today: Zions Bancorp, Jefferies, Amex, Oracle, Novo Nordisk, Lilly, State Street, CSX, and More -- Barrons.com

17. okt 2025, 15:43 UTC

Market Talk

Global Equities Roundup: Market Talk

17. okt 2025, 15:43 UTC

Market Talk

Amazon's Earnings Are About Sentiment of Consumers, Not Investors -- Market Talk

17. okt 2025, 14:58 UTC

Market Talk

Small-Business Trepidation in Canada Points to Economic Decline -- Market Talk

17. okt 2025, 14:41 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

17. okt 2025, 14:35 UTC

Market Talk

Tulu

American Express's Delayed Card Fee Hike Worries Some Investors -- Market Talk

Võrdlus sarnastega

Hinnamuutus

AdvanSix Inc Prognoos

Hinnasiht

By TipRanks

43.74% tõus

12 kuu keskmine prognoos

Keskmine 28 USD 43.74%

Kõrge 28 USD

Madal 28 USD

Põhineb 1 Wall Streeti analüütiku instrumendi AdvanSix Inc 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Osta

1 ratings

Osta

Hoia

Müü

Põhineb 1 analüütiku instrumendi AdvanSix Inc aktsia reitingul - viimase 3 kuu andmed.

Tehniline skoor

By Trading Central

21.435 / 23.29Toetus ja vastupanu

Bullish events outweigh bearish events.

The bullish and bearish events are balanced.

All events are bearish.

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

Ettevõttest AdvanSix Inc

AdvanSix Inc. engages in the manufacture and sale of polymer resins in the United States and internationally. It offers Nylon 6, a polymer resin, which is a synthetic material used to produce fibers, filaments, engineered plastics, and films. The company also provides caprolactam to manufacture polymer resins; ammonium sulfate fertilizers to distributors, farm cooperatives, and retailers; and acetone that are used in the production of adhesives, paints, coatings, solvents, herbicides, and engineered plastic resins, as well as other intermediate chemicals, including phenol, monoisopropylamine, dipropylamine, monoallylamine, alpha-methylstyrene, cyclohexanone, methyl ethyl ketoxime, acetaldehyde oxime, 2-pentanone oxime, cyclohexanol, sulfuric acid, ammonia, and carbon dioxide. It offers its products under the Aegis, Capran, Sulf-N, Nadone, Naxol, and EZ-Blox brands. The company sells its products directly, as well as through distributors. AdvanSix Inc. was incorporated in 2016 and is headquartered in Parsippany, New Jersey.